tirzepatide fda approved for weight loss Unlikely to Exacerbate DR in First Year of Treatment Retatrutide vs Tirzepatide vs Semaglutide

Offered as both an injectable and an oral pill, semaglutide actively mimics GLP-1, a natural hormone, to curtail appetite and promote sustained weight loss

The presence of fibrosis is a key predictor of major adverse liver outcomes (MALO), with risks rising sharply at more advanced stages

Looking ahead : Novo Nordisk has said it plans to ask the FDA to update the label for Wegovy to include the reduced risk of cardiovascular events, which could not only encourage more insurance companies to cover the weight-loss drug, but change how the entire healthcare industry approaches obesity

Off-label use can lead to dosing errors and reduced efficacy

A comparative study conducted between GLP-1RA + Metformin in contrast to cyproterone acetate/ethinylestradiol + Metformin in overweight PCOS women, conducted over a period of 12 weeks, implied that GLP-1 RA+Metformin was superior in reducing the waist circumferences as well as preserving blood sugar levels by improved HbA1c levels and regulating menstrual cycle

(adapted) Loomba R, et al